Research Presentation Sessions: Breast

RPS 2302 - Ways towards personalised breast screening

Lectures

1
Health4Her: implementation of an alcohol brief intervention among women attending a BreastScreen service

Health4Her: implementation of an alcohol brief intervention among women attending a BreastScreen service

07:00Darren J. Lockie, Southbank / AU

2
A clinical risk model for personalised screening and prevention of breast cancer

A clinical risk model for personalised screening and prevention of breast cancer

07:00Mikael Eriksson, Stockholm / SE

3
Which women have the most significant benefit of digital breast tomosynthesis? An automatic density software analysis in the Malmö Breast Tomosynthesis Screening Trial

Which women have the most significant benefit of digital breast tomosynthesis? An automatic density software analysis in the Malmö Breast Tomosynthesis Screening Trial

07:00Jakob Olinder, Lund / SE

4
Risk-based breast screening (RIBBS) in young women: stratification of population and cancer detection rate (CDR) from recruitment

Risk-based breast screening (RIBBS) in young women: stratification of population and cancer detection rate (CDR) from recruitment

07:00Francesca Caumo, Padua / IT

5
Mammographic features of screen-detected breast tumours less than 10mm and risk of breast cancer death

Mammographic features of screen-detected breast tumours less than 10mm and risk of breast cancer death

07:00Nataliia Moshina, Oslo / NO

6
Recall, screen-detected and interval breast cancer for women prevalently screened with digital breast tomosynthesis vs digital mammography

Recall, screen-detected and interval breast cancer for women prevalently screened with digital breast tomosynthesis vs digital mammography

07:00Hildegunn Siv Aase, Isdalstø / NO

7
Clinical feasibility of breast CT as an opportunistic screening modality: a prospective trial of 1614 patients in Switzerland

Clinical feasibility of breast CT as an opportunistic screening modality: a prospective trial of 1614 patients in Switzerland

07:00Anna Landsmann, Zurich / CH

8
A survey by the European Society of Breast Imaging on breast imaging readers’ preferences regarding quality assurance (QA) measures in screening and diagnostic mammography

A survey by the European Society of Breast Imaging on breast imaging readers’ preferences regarding quality assurance (QA) measures in screening and diagnostic mammography

07:00Eleni Michalopoulou, Nottingham / UK

9
Self-reported quality of life for women with screen-detected and symptomatic breast cancer

Self-reported quality of life for women with screen-detected and symptomatic breast cancer

07:00Nataliia Moshina, Oslo / NO

10
Automated breast ultrasound in comparison to 2D mammography, digital breast tomosynthesis, hand-held ultrasound in the detection of breast cancer: a cohort of 4500 examinations

Automated breast ultrasound in comparison to 2D mammography, digital breast tomosynthesis, hand-held ultrasound in the detection of breast cancer: a cohort of 4500 examinations

07:00Athina Vourtsis, Athens / GR

11
Automated breast ultrasound (ABUS) - acquisition and reading times, image quality, recall rates and positive predictive value (PPV) over time: first experience from BRAID trial

Automated breast ultrasound (ABUS) - acquisition and reading times, image quality, recall rates and positive predictive value (PPV) over time: first experience from BRAID trial

07:00Iris Allajbeu, Cambridge / UK

12
Moderation

Moderation

00:00Vicente Martinez de Vega, Madrid / ES

PEP Subscription Required

This course is only accessible for ESR Premium Education Package subscribers.